Medical Devices New Zealand

New Zealand Tissue Engineering Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

New Zealand Tissue Engineering Market Industry Trends and Forecast to 2034: Segmented by (Product, Material, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

New Zealand · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $56.2 Mn Placeholder estimate
Estimate 2025 $63.1 Mn 1.1% of the global market
Projected 2034 $179.1 Mn 184.1% Adds $116.1 Mn over 9 forecast years
CAGR 2025–2034 12.3% Faster than 76% of 147 Medical Devices markets here
Key players 5
  • New Zealand is 1.12% of the global market.
  • In APAC, the largest is China at $533.5 Mn.
  • Fastest growing: India at 14.6% a year.
  • New Zealand ranks 5th of 10 by size in APAC.

Market size projection

New Zealand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$116.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Tissue Engineering Market market size by year, New Zealand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $56.2 Mn — —
2025 (base) $63.1 Mn +$6.9 Mn —
2026 (forecast) $70.8 Mn +$7.8 Mn +12.3%
2027 (forecast) $79.5 Mn +$8.7 Mn +26.1%
2028 (forecast) $89.3 Mn +$9.8 Mn +41.6%
2029 (forecast) $100.3 Mn +$11.0 Mn +59%
2030 (forecast) $112.6 Mn +$12.3 Mn +78.6%
2031 (forecast) $126.5 Mn +$13.9 Mn +100.6%
2032 (forecast) $142.0 Mn +$15.6 Mn +125.2%
2033 (forecast) $159.5 Mn +$17.5 Mn +153%
2034 (forecast) $179.1 Mn +$19.6 Mn +184.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

New Zealand Tissue Engineering Market Analysis at a glance
Market size, 2025$63.1 Mn placeholder estimate
Forecast, 2034$179.1 Mn placeholder estimate
Growth (CAGR), 2025–203412.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, material and end user (see all)
Key playersOrganogenesis, Vericel, Integra Life Sciences Corporation, MiMedx, Smith & Nephew (see all)
Regulator in New ZealandMedsafe (WAND)Source: Medsafe. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The New Zealand Tissue Engineering Market Analysis Executive Summary

Tissue engineering builds living tissue such as skin, cartilage and blood vessels from cells and scaffolds to repair the body.

Key segments of the tissue Engineering market include product (Skin Substitutes, Cartilage and Bone Grafts) and material (Synthetic Scaffolds, Biological Scaffolds and Hydrogels).

Bar chart: New Zealand Tissue Engineering market size, 2024–2034, placeholder estimates. $56.2 Mn in 2024, $63.1 Mn in 2025 and $179.1 Mn in 2034, 12.3% CAGR.
New Zealand Tissue Engineering market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

New Zealand Tissue Engineering Market Dynamics

Market Growth Drivers

Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the tissue Engineering market.

Opportunity

Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the tissue Engineering market.

Market Restraints

Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the tissue Engineering market. Payers are still working out how to pay for one-time cures.

Competitive Landscape for Tissue Engineering Market in New Zealand

The tissue Engineering market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Tissue Engineering Market in New Zealand

Tissue Engineering in New Zealand: rules and payment

Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe.⁠[1] Pharmac decides which medicines and medical devices the public health system pays for.⁠[2]

[1] Medsafe. Checked 14 Nov 2026.

[2] Pharmac. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how tissue Engineering products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in New Zealand.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Tissue Engineering right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Tissue Engineering in context

New Zealand compared

  • Health spending per person: 5,022 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.61 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 2nd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 17.6% of people (2025). World: 10.4% of people (2025). 4th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Tissue Engineering market in New Zealand?
Placeholder estimate: about $63.1 Mn in 2025, rising to about $179.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Tissue Engineering market in New Zealand growing?
Placeholder estimate: about 12.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Tissue Engineering market report cover?
The report splits the market by product (Skin Substitutes, Cartilage, Bone Grafts, Vascular Grafts), material (Synthetic Scaffolds, Biological Scaffolds, Hydrogels) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Tissue Engineering market?
Key players include Organogenesis, Vericel, Integra Life Sciences Corporation, MiMedx and Smith & Nephew.
What is driving the Tissue Engineering market?
Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the tissue Engineering market.
Who regulates Tissue Engineering in New Zealand?
Medical devices do not need approval before sale, but suppliers must notify them to the WAND database run by Medsafe. Source: Medsafe. Checked 14 Nov 2026.
How is healthcare paid for in New Zealand?
Pharmac decides which medicines and medical devices the public health system pays for. Source: Pharmac. Checked 14 Nov 2026.
How much research is published on Tissue Engineering?
PubMed lists 26,507 papers on Tissue Engineering added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in New Zealand

See all

Related on wounds and burns and bones and joints

See the topic